Global Antifungal Therapeutics Industry Opportunities & 2014 Trends New Study Now Available at MarketReportsOnline.com
Dallas, Texas (PRWEB) October 04, 2014 -- Over the past several years, there have been high incidences of invasive fungal infections around the globe. In response to this, various antifungal agents with novel action mechanisms, broader action spectrum and fewer side effects have emerged. Growth within global antifungal therapeutics market is driven by high number of cases of fungal infections, rise in number of immune-compromised aged population and various government initiatives in this field. Some of the restraints to market’s growth are growing resistance to antifungal drugs, limitations with antifungal drugs, presence of generics and government regulations in pharmaceutical industry. Major trends prevailing in the industry includes growth in resistant strains and Candida & Aspergillus causing maximum fungal infections.
Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=351337.
Antifungal agents are drugs used for the treatment of fungal infections that can infect almost any part of the body including skin, nails, respiratory tract, urogenital tract and alimentary tract. Treatment of fungal infections currently available in the market can be broadly classified into four major classes of antifungal drugs – Polyenes, Azoles, Allylamines and Echinocandins. Global antifungal market is dominated by systemic antifungal infection.
Segment Coverage: Polyenes, Azoles, Echinocandins and Allylamines
Company Coverage: Merck & Co., Inc., Pfizer Inc., Astellas Pharma Inc. and SCYNEXIS Inc.
The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and Allylamines. It provides broad coverage of these classes with detailed analysis of drugs and indications in respective classes. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). Further, key players of the industry such as Merck & Co., Inc., Pfizer Inc., Astellas Pharma Inc. and Noble Corporation SCYNEXIS, Inc. are also profiled in the report.
List of Figures
Figure 1: Site of Action of the Common Antifungal Agents in Generalized Fungal Cell
Figure 2: Global Antifungal Therapeutics Market Size by Value, 2011-13 (US$ Billions)
Figure 3: Global Antifungal Therapeutics Market Size by Value Forecasted, 2014E-19E (US$ Billions)
Figure 4: Global Antifungal Therapeutics Market Share by Region (2012E)
Figure 5: Global Antifungal Market by Organisms Causing Fungal Infection (2013)
Figure 6: Global Antifungal Drug Class Market Share by Value (2013)
Figure 7: Global Antifungal Drug Class Market Share by Volume (2013)
Figure 8: Global Antifungal Drug Type Market Share by Value (2013)
Figure 9: Global Antifungal Drug Type Market Share by Volume (2013)
Figure 10: Structure of Some Common Polyene Antifungal Agents
Explore more reports on Pharmaceuticals Market @ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
About Us:
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 supports to our customers through phone and email communication. Not limited to the pharmaceuticals market, MarketReportsOnline.com offers research studies on medical devices, chemicals, agriculture, environment, biotechnology, agriculture, retail, energy and power, semiconductor and electronics, it & telecommunication, food and beverages, advanced materials, banking and financial services market, mining & utilities, travel & hospitality, healthcare and much more.
Ritesh Tiwari, Market Reports Online, http://www.marketreportsonline.com/, +1 (888) 391-5441, [email protected]
Share this article